Tahoe Therapeutics
PrivateLast Round
Series A
Aug 11, 2025
Est. Valuation
$120M
Total Funding Raised
$42.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tahoe Therapeutics is a biotechnology company that develops AI-powered models of the human cell to facilitate the design of better drugs for patients, with an initial focus on cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Synthetic Data
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tahoe Therapeutics Comparables
Compare Tahoe Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 82% | |
| Gordian Biotechnology | 82% | |
| Noetik | 80% | |
Tahoe Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 11, 2025 | ||||
| Seed | Dec 8, 2022 |
Key People
Founding team and executive leadership
Tahoe Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Camford Capital | Seed |
| Mubadala Capital Ventures | Series A |
| Conviction Investment Partners | Series A |
| Venture Highway | Series A, Seed |
| Mubadala Capital | Series A, Seed |
| Wing Venture Capital | Series A, Seed |
| Amplify Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Announced Tahoe-x1 for rapid ML model iteration.
- Jan 1, 2026
Launched Tahoe-100M, a large-scale single-cell dataset for training foundation models.
Tahoe Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tahoe Therapeutics's valuation, stock price, and market status.